07:00 , May 16, 2016 |  BioCentury  |  Finance

Global ambitions

European biotechs not only missed out on the extended bull market that allowed U.S. biotechs to fill their coffers, but also on what could have been an arbitrage opportunity for U.S. investors who found domestic...
07:00 , Apr 25, 2016 |  BC Week In Review  |  Financial News

DalCor completes venture financing

DalCor Pharma U.K. Ltd. , London, U.K.   Business: Cardiovascular   Date completed: 2016-04-19   Type: Venture financing   Raised: $100 million   Investors: Sanderling; Caisse de Depot et Placement du Quebec; Fonds de solidarite...
01:00 , Apr 20, 2016 |  BC Extra  |  Financial News

DalCor raises $100M in series B

DalCor Pharma U.K. Ltd. (London, U.K.) raised $100 million in a series B round with Sanderling Ventures, Andre Desmarais, Caisse de depot et placement du Quebec, the Fonds de solidarite FTQ, CTI Life Sciences and...
08:00 , Jan 19, 2015 |  BC Week In Review  |  Financial News

CTI Life Sciences Fund financial update

CTI Life Sciences Fund , Montreal, Quebec   Business: Finance   Date announced: 2015-01-15   Note: CTI Life Sciences raised C$134 million ($112.9 million) in the first close of its second fund, CTI II. The...
03:50 , Jan 16, 2015 |  BC Extra  |  Financial News

CTI raises C$134M toward second fund

Canadian venture firm CTI Life Sciences raised C$134 million ($112.9 million) in the first close of its second fund, CTI II. The firm aims to close the fund with a total of C$175 million ($147.4...
07:00 , Sep 9, 2013 |  BioCentury  |  Finance

E round in the hand vs. IPO in the bush

The stars have yet to align for Argos Therapeutics Inc. 's pursuit of a public listing. An IPO attempt last year fizzled in poor market conditions, and when the window opened several months ago, the...
07:00 , Sep 2, 2013 |  BC Week In Review  |  Financial News

Argos completes venture financing

Argos Therapeutics Inc. , Durham, N.C.   Business: Cancer, Infectious   Date completed: 8/26/13   Type: Venture financing   Raised: $42.5 million   Investors: Pharmstandard International; Green Cross; Forbion Capital Partners; TVM Capital; Lumira Capital;...
00:07 , Aug 27, 2013 |  BC Extra  |  Financial News

Argos raises $42.5M in series E

Argos Therapeutics Inc. (Durham, N.C.) raised $42.5 million in a series E round led by new investor Pharmstandard International S.A., a holding company of Pharmstandard OJSC (RTS:PHST; LSE:PHST). New investor Green Cross Corp. (KSE:006280) also...
07:00 , Apr 30, 2012 |  BC Week In Review  |  Financial News

Argos completes venture financing

Argos Therapeutics Inc. , Durham, N.C.   Business: Cancer, Infectious   Date completed: 4/24/12   Type: Venture financing   Raised: $25 million   Investors: Forbion Capital Partners; TVM Capital; Lumira Capital; Intersouth Partners; Caisse de...
01:04 , Apr 25, 2012 |  BC Extra  |  Financial News

Argos raises $25 million

Argos Therapeutics Inc. (Durham, N.C.) raised $25 million in a series D round led by existing investor Forbion Capital Partners. Other existing investors participated, including TVM Capital; Lumira Capital: Intersouth Partners; Caisse de depot et...